Faculty Opinions recommendation of Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps.

By M. Kiebler, Jacki E Heraud. 2009

904 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/4a1bc9dadd2d0b2005dab3636b7bc85b7cfb09a3

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

Citations in the corpus

Resolving RNA complexity to decipher regulatory rules governing biological networks (2010, neutral): “CLIP (and emerging methodological improvements to this metho”
Predicting effective microRNA target sites in mammalian mRNAs (2015, methodology): “…expansive sets of computational predictions (e.g., all mRNAs with a 6mer site) to relatively small sets of biochemically supported predictions ( Chi et al., 2009 ; Lipchina et al., 2011 ; Loeb et al., 2012 ; Grosswendt et al., 2014 ; Tan et al., 2014 ). mRNAs with expression signals…”
Posttranscriptional regulation of microRNA biogenesis in animals. (2010, methodology): “The HITS-CLIP (high-throughput sequencing of RNAs isolated by crosslinking immunoprecipitation) method recently developed to decode miRNA-mRNA interactions (Chi et al., 2009) can be applied to the identification of factors that regulate miRNA biogenesis.”
Lost in translation: an assessment and perspective for computational microRNA target identification (2009, background): “…cardiovascular and neurodegenerative diseases (Hebert and De Strooper, 2007; Hebert et al., 2008; Zhang, 2008) as well as in human malignancies (Croce and Calin, 2005; Esquela-Kerscher and Slack, 2006; Fabbri et al., 2007; Gartel and Kandel, 2008; Garzon et al., 2006; Slack and Weidhaas,…”
Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP (2010, methodology): “Studies using conventional UV 254 nm CLIP have not reported the incidence of deletions and substitutions (Chi et al., 2009; Licatalosi et al., 2008; Ule et al., 2003; Zisoulis et al., 2010), except for recent work by Grannemann et al. on the U3 snoRNA that showed an increase of deletions at the RBP…”
Metazoan MicroRNAs (2018, background): “34 Cell 173, March 22, 2018 miRNA silencing complexes bind to many sites that lack contiguous 6 nt matches to the seed region, such that in aggregate these noncanonical sites account for approximately half of the intracellular crosslinks (Chi et al., 2009; Hafner et al., 2010; Loeb et al., 2012; Hel”
An overview of microRNAs (2015, background): “Argonaute antibodies, with or without prior RNA crosslinking, and definition of bound target RNAs by microarray or NGS profiling[104-107].”
miR-19 is a key oncogenic component of mir-17-92. (2009, background): “Recent bioinformatic predictions and several experimental validations also suggest that each miRNA is likely to regulate hundreds of mRNA targets and fine-tune their expression in a cell type-dependent and context-dependent manner (Baek et al. 2008; Selbach et al. 2008; Chi et al. 2009).”
MicroRNAs in Common Human Diseases (2012, methodology): “Recent advancement of molecular biology techniques, such as RISC immune-precipitation and Argonauteprotein crosslinking immune-precipitation, provide valuable tools allowing target enrichment before bioinformatic predications [108,109].”
Next-Generation Genomics: an Integrative Approach (2010, positive): “ChIP–chip and ChIP–seq are able to provide genome-scale information on DNA–protein interactions, and high-throughput sequencing of RNAs isolated by crosslinking and immunoprecipitation ( HITS-CLIP , also known as CLIP–seq) is emerging as an important method for understanding RNA–protein interaction”
MicroRNAs in human cancer. (2013, background): “[ 118 ] ) or deep sequencing technology after immunoprecipitation of miRNAs and mRNAs complexed with AGO, the main component of the miRNA effector complex, to not only identify mRNA targets, but also localize their precise binding sites [ 190, 191 ] .”